Stem Cell Applications in Diabetes and Metabolic Disorders
Stem cell research is providing new opportunities for developing innovative treatments for diabetes and metabolic diseases. This area explores how stem cells can be used to understand disease mechanisms and develop regenerative therapies. Researchers will discuss pancreatic cell regeneration, insulin-producing cell development, and transplantation approaches. The topic highlights advancements in stem cell-based models for studying metabolic disorders and testing new treatments. Experts will address challenges related to immune rejection, cell functionality, and long-term therapeutic outcomes. Discussions will focus on emerging strategies for restoring metabolic balance through regenerative approaches. This area provides insights into the future potential of stem cells in managing chronic metabolic conditions.
- Pancreatic beta-cell regeneration
- Stem cell therapies for diabetes
- Disease modeling using stem cells
Related Conference of Stem Cell Applications in Diabetes and Metabolic Disorders
November 16-17, 2026
19th International Conference on Human Genomics and Genomic Medicine
Tokyo, Japan
February 18-19, 2027
22nd World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Singapore City, Singapore
March 11-12, 2027
17th International Conference on Human Genetics and Genetic Diseases
Berlin, Germany
Stem Cell Applications in Diabetes and Metabolic Disorders Conference Speakers
Recommended Sessions
- Adult Stem Cells and Tissue-Specific Stem Cells
- Artificial Intelligence, Bioinformatics, and Stem Cell Research
- Cancer Stem Cells and Oncology Applications
- Embryonic Stem Cells and Induced Pluripotent Stem Cells
- Future Perspectives and Innovations in Stem Cell Research
- Gene Editing and Stem Cell Engineering
- Organoids, 3D Cell Culture, and Advanced Stem Cell Models
- Regenerative Medicine and Tissue Engineering
- Stem Cell Applications in Diabetes and Metabolic Disorders
- Stem Cell Applications in Immunology and Immune Therapies
- Stem Cell Applications in Wound Healing and Skin Regeneration
- Stem Cell Biology and Fundamental Research
- Stem Cell Ethics, Regulations, and Clinical Translation
- Stem Cell Manufacturing and Bioprocessing Technologies
- Stem Cell-Based Drug Discovery and Disease Modeling
- Stem Cell-Based Therapies and Clinical Applications
- Stem Cells in Cardiovascular Regeneration
- Stem Cells in Neurological Disorders and Brain Repair
- Stem Cells in Ophthalmology and Vision Restoration
- Stem Cells in Orthopedics and Musculoskeletal Regeneration
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Advanced Imaging and Single-Cell Technologies - cellscience-cs-2027 (UK)
- Animal Genetics - Genome 2027 (Germany)
- Artificial Intelligence in Cell and Molecular Research - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - Genome 2027 (Germany)
- Biomarkers and Microarrays - Genome 2027 (Germany)
- Biotechnology and Molecular Therapeutics - cellscience-cs-2027 (UK)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Cell Biology and Molecular Oncology - cellscience-cs-2027 (UK)
- Cancer Genomics - Genome 2027 (Germany)
- Cell Biology and Cellular Mechanisms - cellscience-cs-2027 (UK)
- Cellular Metabolism and Metabolic Biology - cellscience-cs-2027 (UK)
- Cellular signaling and Signal Transduction - cellscience-cs-2027 (UK)
- Clinical genomics - Genome 2027 (Germany)
- Comparative Genomics - Genome 2027 (Germany)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Emerging Technologies and Future Directions in Cell Science - cellscience-cs-2027 (UK)
- Epigenomics and Epigenetics - Genome 2027 (Germany)
- Functional Genomics - Genome 2027 (Germany)
- Gene Editing and Genetic Engineering - Genome 2027 (Germany)
- Genetic Disorder - Genome 2027 (Germany)
- Genetics, Genomics and Genome Biology - cellscience-cs-2027 (UK)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Genomic Instability - Genome 2027 (Germany)
- Genomic Medicine - Genome 2027 (Germany)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Immunology and Cellular Immunity - cellscience-cs-2027 (UK)
- Microbial Genomics - Genome 2027 (Germany)
- Molecular Biology and Gene Regulation - cellscience-cs-2027 (UK)
- Molecular Diagnostics and Biomarkers - cellscience-cs-2027 (UK)
- Molecular Medicine and Translational Research - cellscience-cs-2027 (UK)
- Molecular Microbiology and Host–Pathogen Interactions - cellscience-cs-2027 (UK)
- Next generation sequencing - Genome 2027 (Germany)
- Nutrigenomics - Genome 2027 (Germany)
- Personalized and Regenerative Medicine - Genome 2027 (Germany)
- Pharmacogenomics - Genome 2027 (Germany)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Plant Genomics and Molecular Pharming - Genome 2027 (Germany)
- Stem Cell Biology and Regenerative Medicine - cellscience-cs-2027 (UK)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Structural Genomics - Genome 2027 (Germany)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)
- Trends in Genomics and Pharmacogenomics - Genome 2027 (Germany)